FDA clears ResMed's OSA (obstructive sleep apnoea) product platform:
This article was originally published in Clinica
Executive Summary
ResMed has received US FDA 510(k) clearance to market its S7 Elite CPAP and AutoSet Spirit autotitrating devices for treating obstructive sleep apnoea (OSA). Both systems offer fully integrated heated humidification options and use system hardware common to both units, allowing accessories to be added or interchanged between models and ultimately streamlining inventory management, says the San Diego, California firm. The integrated devices are smaller and quieter than ResMed's current product line.